NDAORALFOR SOLUTION
Approved
Dec 2017
Lifecycle
LOE Approaching
Competitive Pressure
15/100
Mechanism of Action
Growth Hormone Secretagogue Receptor Agonists
Pharmacologic Class:
Growth Hormone Secretagogue Receptor Agonist
Loss of Exclusivity
LOE Date
Oct 12, 2027
19 months away
Patent Expiry
Oct 12, 2027
Patent Records (1)
| Patent # | Expiry | Type | Use Code |
|---|---|---|---|
| 8192719 | Oct 12, 2027 | U-2220 |